公开(公告)号：BG101112A

公开(公告)日：1998-04-30

申请号：BG10111297

申请日：1997-01-06

Applicant: BASF AG

Inventor： HELLENDAHL BEATE ,  LANSKY ANNEGRET ,  RENDENBAUH-MUELLER BEATRICE ,  BACH ALFRED ,  UNGER LILIANE ,  IESCHENDORF HANS-JUERGEN ,  WICKE CARSTEN

IPC: C07D233/84 ,  A61K31/33 ,  A61K31/415 ,  A61K31/44 ,  A61K31/4402 ,  A61K31/4406 ,  A61K31/4409 ,  A61K31/4418 ,  A61K31/4425 ,  A61K31/445 ,  A61K31/495 ,  A61K31/496 ,  A61P25/18 ,  A61P25/20 ,  A61P25/24 ,  A61P25/26 ,  C07D213/56 ,  C07D213/64 ,  C07D213/65 ,  C07D213/70 ,  C07D213/73 ,  C07D213/79 ,  C07D213/81 ,  C07D233/90 ,  C07D307/79 ,  C07D333/24 ,  C07D333/28 ,  C07D333/38 ,  C07D471/18

Abstract: The invention relates to the use of heterocyclic compoundswith the formula Het-A-Ar, where Het, A, B & Ar have the meaningslisted in the description. The compounds have high affinity todiopamin-D3-receptors and for this reason are used for thetreatment of diseases reacting to dopamin-D3-ligands.12 claims